α-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin β1/β3 downregulation

Puchsaka,Punyawee; Chaotham,Chatchai; Chanvorachote,Pithi

doi:10.3892/ijo.2016.3624

α-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin β1/β3 downregulation

Authors:
- Punyawee Puchsaka
- Chatchai Chaotham
- Pithi Chanvorachote
View Affiliations

Affiliations: Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand, Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
Published online on: July 18, 2016 https://doi.org/10.3892/ijo.2016.3624
Pages: 1445-1456

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chemotherapeutic failure and metastasis are the main causes of high mortality rate in lung cancer. Alteration of cellular redox status in response to endogenous stimuli or exogenous compounds has a significant impact on cell signaling and behavior. Herein we divulge for the first time that lung cancer cells exposed to α-lipoic acid (LA) resulted in a higher level of cellular superoxide anion (O2·-) and hydrogen peroxide (H2O2), and such an increase of the specific reactive oxygen species (ROS) downregulated integrin β1 and β3, the integrins known for potentiating aggressive behavior and metastasis. The LA-treated cells exhibited significant decrease in their abilities to survive in detached condition and grow in anchorage-independent soft agar assay. Furthermore, LA sensitized the cells to cisplatin, etoposide and paclitaxel-induced apoptosis. For underlying mechanism, we found that the treatment of the cells with LA significantly decreased integrin β1 and β3, while had no effect on integrin α5 and αv. Interestingly, survival protein p-AKT and anti-apoptotic protein Bcl-2 were reduced in an association to such integrin modulations. Using ROS probes and selective anti-oxidants, we have shown that H2O2 and O2·- induced by LA are key players for the decrease of β1 and β3 integrins, respectively. These findings indicate a novel effect of LA as well as specific ROS, O2·- and H2O2 in integrin regulation, anoikis and chemotherapeutic sensitizations.

View Figures

View References

1	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
2	Hunter KW, Crawford NPS and Alsarraj J: Mechanisms of metastasis. Breast Cancer Res. 10(Suppl 1): S2. 2008. View Article : Google Scholar :
3	Merk J, Rolff J, Dorn C, Leschber G and Fichtner I: Chemoresistance in non-small-cell lung cancer: Can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? Eur J Cardiothorac Surg. 40:e29–e33. 2011. View Article : Google Scholar : PubMed/NCBI
4	Paoli P, Giannoni E and Chiarugi P: Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI
5	Igney FH and Krammer PH: Death and anti-death: Tumour resistance to apoptosis. Nat Rev Cancer. 2:277–288. 2002. View Article : Google Scholar : PubMed/NCBI
6	Liu Q-H, Shi M-L, Sun C, Bai J and Zheng J-N: Role of the ERK1/2 pathway in tumor chemoresistance and tumor therapy. Bioorg Med Chem Lett. 25:192–197. 2015. View Article : Google Scholar
7	McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 1773:1263–1284. 2007. View Article : Google Scholar
8	Wilson TR, Longley DB and Johnston PG: Chemoresistance in solid tumours. Ann Oncol. 17(Suppl 10): x315–x324. 2006. View Article : Google Scholar : PubMed/NCBI
9	Brognard J, Clark AS, Ni Y and Dennis PA: Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61:3986–3997. 2001.PubMed/NCBI
10	Pommier Y, Sordet O, Antony S, Hayward RL and Kohn KW: Apoptosis defects and chemotherapy resistance: Molecular interaction maps and networks. Oncogene. 23:2934–2949. 2004. View Article : Google Scholar : PubMed/NCBI
11	West KA, Castillo SS and Dennis PA: Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat. 5:234–248. 2002. View Article : Google Scholar
12	Wongvaranon P, Pongrakhananon V, Chunhacha P and Chanvorachote P: Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. Anticancer Res. 33:5433–5444. 2013.PubMed/NCBI
13	Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-κB in development and progression of human cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
14	Chiarugi P and Giannoni E: Anoikis: A necessary death program for anchorage-dependent cells. Biochem Pharmacol. 76:1352–1364. 2008. View Article : Google Scholar : PubMed/NCBI
15	Adams JM and Cory S: Bcl-2-regulated apoptosis: Mechanism and therapeutic potential. Curr Opin Immunol. 19:488–496. 2007. View Article : Google Scholar : PubMed/NCBI
16	Sartorius UA and Krammer PH: Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer. 97:584–592. 2002. View Article : Google Scholar : PubMed/NCBI
17	Harada T, Ogura S, Yamazaki K, Kinoshita I, Itoh T, Isobe H, Yamashiro K, Dosaka-Akita H and Nishimura M: Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers. Cancer Sci. 94:394–399. 2003. View Article : Google Scholar : PubMed/NCBI
18	Velling T, Nilsson S, Stefansson A and Johansson S: beta1-Integ-rins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases. EMBO Rep. 5:901–905. 2004. View Article : Google Scholar : PubMed/NCBI
19	Bhattacharya S, Ray RM and Johnson LR: Integrin beta3-mediated Src activation regulates apoptosis in IEC-6 cells via Akt and STAT3. Biochem J. 397:437–447. 2006. View Article : Google Scholar : PubMed/NCBI
20	Zheng DQ, Woodard AS, Tallini G and Languino LR: Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J Biol Chem. 275:24565–24574. 2000. View Article : Google Scholar : PubMed/NCBI
21	Ivaska J, Nissinen L, Immonen N, Eriksson JE, Kähäri VM and Heino J: Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta. Mol Cell Biol. 22:1352–1359. 2002. View Article : Google Scholar : PubMed/NCBI
22	Dozio E, Ruscica M, Passafaro L, Dogliotti G, Steffani L, Marthyn P, Pagani A, Demartini G, Esposti D, Fraschini F, et al: The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells. Eur J Pharmacol. 641:29–34. 2010. View Article : Google Scholar : PubMed/NCBI
23	Feuerecker B, Pirsig S, Seidl C, Aichler M, Feuchtinger A, Bruchelt G and Senekowitsch-Schmidtke R: Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo. Cancer Biol Ther. 13:1425–1435. 2012. View Article : Google Scholar : PubMed/NCBI
24	Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Chanvorachote P and Rojanasakul Y: Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J Pharmacol Exp Ther. 319:1062–1069. 2006. View Article : Google Scholar : PubMed/NCBI
25	Simbula G, Columbano A, Ledda-Columbano GM, Sanna L, Deidda M, Diana A and Pibiri M: Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis. 12:113–123. 2007. View Article : Google Scholar
26	Wenzel U, Nickel A and Daniel H: α-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O₂^−·-generation. Apoptosis. 10:359–368. 2005. View Article : Google Scholar : PubMed/NCBI
27	Maiuthed A and Chanvorachote P: Cisplatin at sub-toxic levels mediates integrin switch in lung cancer cells. Anticancer Res. 34:7111–7117. 2014.PubMed/NCBI
28	Caccavari F, Valdembri D, Sandri C, Bussolino F and Serini G: Integrin signaling and lung cancer. Cell Adhes Migr. 4:124–129. 2010. View Article : Google Scholar
29	Guadamillas MC, Cerezo A and Del Pozo MA: Overcoming anoikis - pathways to anchorage-independent growth in cancer. J Cell Sci. 124:3189–3197. 2011. View Article : Google Scholar : PubMed/NCBI
30	Aoudjit F and Vuori K: Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene. 20:4995–5004. 2001. View Article : Google Scholar : PubMed/NCBI
31	Hodkinson PS, Mackinnon AC and Sethi T: Extracellular matrix regulation of drug resistance in small-cell lung cancer. Int J Radiat Biol. 83:733–741. 2007. View Article : Google Scholar : PubMed/NCBI
32	Meadows GG: Integration/Interaction of Oncologic Growth. Springer Science & Business Media; 2005, View Article : Google Scholar
33	Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U, Pongrakhananon V, Wang L and Chanvorachote P: Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem. 285:38832–38840. 2010. View Article : Google Scholar : PubMed/NCBI
34	Pongrakhananon V, Nimmannit U, Luanpitpong S, Rojanasakul Y and Chanvorachote P: Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation. Apoptosis. 15:574–585. 2010. View Article : Google Scholar : PubMed/NCBI
35	Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, Castranova V and Rojanasakul Y: Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells. Mol Pharmacol. 73:119–127. 2008. View Article : Google Scholar
36	Rungtabnapa P, Nimmannit U, Halim H, Rojanasakul Y and Chanvorachote P: Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation. Am J Physiol Cell Physiol. 300:C235–C245. 2011. View Article : Google Scholar :
37	Chanvorachote P, Pongrakhananon V, Wannachaiyasit S, Luanpitpong S, Rojanasakul Y and Nimmannit U: Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation. Cancer Invest. 27:624–635. 2009. View Article : Google Scholar : PubMed/NCBI
38	Shi DY, Liu HL, Stern JS, Yu PZ and Liu SL: Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway. FEBS Lett. 582:1667–1671. 2008. View Article : Google Scholar : PubMed/NCBI
39	Giancotti FG and Ruoslahti E: Integrin signaling. Science. 285:1028–1032. 1999. View Article : Google Scholar : PubMed/NCBI
40	Vivanco I and Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. 2002. View Article : Google Scholar : PubMed/NCBI
41	Zahreddine H and Borden KL: Mechanisms and insights into drug resistance in cancer. Front Pharmacol. 4:282013. View Article : Google Scholar : PubMed/NCBI
42	Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, et al: Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med. 5:662–668. 1999. View Article : Google Scholar : PubMed/NCBI
43	Morello V, Cabodi S, Sigismund S, Camacho-Leal MP, Repetto D, Volante M, Papotti M, Turco E and Defilippi P: β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. Oncogene. 30:4087–4096. 2011. View Article : Google Scholar : PubMed/NCBI
44	Schooley AM, Andrews NM, Zhao H and Addison CL: β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner. Cancer Lett. 316:157–167. 2012. View Article : Google Scholar
45	Ninsontia C and Chanvorachote P: Ouabain mediates integrin switch in human lung cancer cells. Anticancer Res. 34:5495–5502. 2014.PubMed/NCBI
46	Clerkin JS, Naughton R, Quiney C and Cotter TG: Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett. 266:30–36. 2008. View Article : Google Scholar : PubMed/NCBI
47	Luanpitpong S, Chanvorachote P, Nimmannit U, Leonard SS, Stehlik C, Wang L and Rojanasakul Y: Mitochondrial super-oxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitination. Biochem Pharmacol. 83:1643–1654. 2012. View Article : Google Scholar : PubMed/NCBI
48	Luanpitpong S, Nimmannit U, Chanvorachote P, Leonard SS, Pongrakhananon V, Wang L and Rojanasakul Y: Hydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanism. Apoptosis. 16:769–782. 2011. View Article : Google Scholar : PubMed/NCBI
49	Songserm T, Pongrakhananon V and Chanvorachote P: Sub-toxic cisplatin mediates anoikis resistance through hydrogen peroxide-induced caveolin-1 up-regulation in non-small cell lung cancer cells. Anticancer Res. 32:1659–1669. 2012.PubMed/NCBI
50	Dicter N, Madar Z and Tirosh O: α-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria. J Nutr. 132:3001–3006. 2002.PubMed/NCBI
51	Çakatay U, Kayali R, Sivas A and Tekeli F: Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle. Arch Gerontol Geriatr. 40:231–240. 2005. View Article : Google Scholar : PubMed/NCBI
52	Biewenga GP, Haenen GR and Bast A: The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 29:315–331. 1997. View Article : Google Scholar : PubMed/NCBI
53	Packer L, Witt EH and Tritschler HJ: alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med. 19:227–250. 1995. View Article : Google Scholar : PubMed/NCBI
54	Ziech D, Franco R, Georgakilas AG, Georgakila S, Malamou-Mitsi V, Schoneveld O, Pappa A and Panayiotidis MI: The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact. 188:334–339. 2010. View Article : Google Scholar : PubMed/NCBI